Shilpa Medicare

Shilpa Medicare

SHILPAMED

 ₹ 864.51
 ₹ 53.61
6.61%
Healthcare
 ₹ 0.00
(%)1D
Updated: 14 Nov 2024, 03:31:23 pm IST
Stock Score
Open Price
 ₹ 834.01
Prev. Close
 ₹ 810.90
 ₹ 806.23
Day Low
 ₹ 885.08
Day High

 ₹ 296.20
52 Week Low
 ₹ 973.92
52 Week High

Quick Bite

Price To Earnings Ratio

-231.15

Sector PE

67.58

PB Ratio

4.21

Sector PB

8.81

EPS

-3.74

Dividend Yield

0.00

Today's Volume

909.229 K

5 Day Avg. Volume

466.275 K

PEG Ratio

1.51

Market Cap.

₹ 8,330.00 Cr.

Returns Comparison

TimeSHILPAMEDVSIndustry
1 Day6.61%0.62%
1 Week4.76%-3.89%
1 Month-1.53%-7.55%
6 Months50.69%14.29%
1 Year128.2%48.6%

StockGro Trade Views 👍

StockGro Trade Views 👍

Technical Trend

Bullish
academy home
Bearish
Neutral
Bullish

Pivot Levels

R3 ₹ 976.50
R2 ₹ 930.79
R1 ₹ 897.65
RESISTANCE
 ₹ 851.94
SUPPORT
S1 ₹ 818.80
S2 ₹ 773.09
S3 ₹ 739.95

Updated: 22 Jul 2024,09:18:33 am IST

Moving Averages

Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
0
Buy
6
Period (Days)SMAIndication
10850.59Bullish
20834.13Bullish
30837.1Bullish
50841.92Bullish
100757.32Bullish
200613.92Bullish

Updated: 14 Nov 2024, 03:30:00 pm IST

Analyst Rankings 👍

Analyst Rankings 👍

Shareholding Updates

PromotersPublicFIIDIIOthers
44.33%
Promoters
Sep 2024
Promoters  44.33%
FII  9.59%
DII  8.17%
Public  37.9%
Others  0.01%

Mutual Fund Ownership 👍

Mutual Fund Ownership 👍

Cash Flow

AnnualFY 2023FY 2022FY 2021
Operating Activities226.17105.1346.93
Investing Activities-278.48-285.50-404.28
Financing Activities45.8082.86436.37
Net Cash Flow-6.51-97.5179.03

All Figures in ₹ Cr., unless mentioned otherwise

Ratios

Return on Equity (%)

Income Statement

All Figures in ₹ Cr., unless mentioned otherwise

Balance Sheet

All Figures in ₹ Cr., unless mentioned otherwise

Peer Comparison

Name1D (%)1W (%)1M (%)6M (%)1Y (%)
Shilpa Medicare6.614.76-1.5350.69128.2
Aarti Drugs0.3-4.96-7.063.534.5
Abbott India-0.59-1.45-4.840.0916.69
Advanced Enzyme Tech1.41-22.43-25.25-4.9717.9
Ajanta Pharmaceuticals1.43-2.7-14.648.2745.89
Returns as on 15 Nov, 2024

About Shilpa Medicare

Shilpa Medicare Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of active pharmaceutical ingredients (APIs), formulation and development service. It is engaged in APIs, intermediates, formulations, new drug delivery systems, peptides / biotech products and specialty chemicals, and others. The Company supplies more than 30 oncology APIs including key products such as Capecitabine, Gemcitabine Hydrochloride, Pemetrexed, Axitinib, Erlotinib Hydrochloride and Irinotecan Hydrochloride for various international markets including United States of America, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. Its non-Oncology API products include Ambroxol (Mucolytic agent), Tranexmic Acid and Ursodeoxycholic Acid. Its Injectable Dosage Forms include Myelodysplastic Syndrome, Breast Cancer, Multiple Myeloma, and more. Its Oral Solid Dosage Forms include Psoriasis, Prostate Cancer, Multiple Sclerosis, and others.

Shilpa Medicare Share Price

Shilpa Medicare Limited is an Indian pharmaceutical company. The company's field of activity is research and development, production and sale of oncology drugs and preparations. Its products consist of oncology and non-oncology active ingredients (APIs), oncology formulations, biosimilars, ophthalmic, orodispersible films, biochemical diagnostics, organic intermediates, testing and manufacturing scales, and transdermal patches. It provides oncology APIs and middleware. Its oncology/non-oncology APIs include capecitabine, gemcitabine hydrochloride, axitinib, erlotinib HCL and irinotecan HCL trihydrate in several regulated markets including the US, Europe, Japan, South Korea, Russia, Mexico, Brazil and other emerging markets. Its non-oncology API products include Ambroxol (a mucolytic agent) in Europe and Tranexamic Acid and Ursodeoxycholic Acid in India. The company also manufactures and sells Lenvatinib capsules under the Lenshil brand.

Shilpa Medicare FAQs

How to Buy Shilpa Medicare Share?

up
To purchase Shilpa Medicare shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Shilpa Medicare (ticker symbol: SHILPAMED) on the trading platform provided by your broker and purchase the shares.

What's Shilpa Medicare share price today?

up
The stock price of Shilpa Medicare as of 14 Nov 2024 is ₹864.51

What is the Market Cap of Shilpa Medicare?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 14 Nov 2024, Shilpa Medicare (ticker symbol: SHILPAMED) has a market capitalisation of approximately ₹83,30,00,00,000.00

What is the PE and PB ratio of Shilpa Medicare?

up
Shilpa Medicare Ltd's price-to-book ratio as of 14 Nov 2024 is 4.21, reflecting the market's valuation compared to its asset value. As of 14 Nov 2024, the trailing twelve months P/E (price-to-earnings) ratio is -231.15, indicating the market values the company at around - ₹231.15 for every ₹1 of earnings

What is the 52 Week High and Low of Shilpa Medicare Share?

up
Shilpa Medicare Ltd (SHILPAMED) hit its 52-week high at ₹973.92, and its 52-week low at ₹296.20.
Want to learn and earn in Stocks?
Login/Register
Start Learning